2. QUALITATIVE AND QUANTITATIVE …
Version 1.0 1 NEW ZEALAND DATA SHEET . 1. PRODUCT NAME Arrow – Roxithromycin 150, 150 mg, coated tablets Arrow – Roxithromycin …
Download 2. QUALITATIVE AND QUANTITATIVE …
Information
Domain:
Source:
Link to this page:
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
ICD-10 Common Codes - Quest Diagnostics : …
www.questdiagnostics.comDiagnostic Services Test List ICD-10 Common Codes ICD-10 Code Description A63.8 Other Specified Predominantly Sexually Transmitted Diseases A64 Unspecified Sexually Transmitted Disease
DRUG NAME: Octreotide - BC Cancer
www.bccancer.bc.caOctreotide BCCA Cancer Drug Manual© Page 1 of 9 Octreotide Developed: 2001 Revised: 1 July 2015 DRUG NAME: Octreotide SYNONYM(S): Octreotide acetate, SMS 201 -995, synthetic octapeptide analogue of somatostatin, SMS LAR COMMON TRADE NAME(S):
www.painmedassociates.com
www.painmedassociates.comPAIN MEDICINE ASSOCIATES PMA Patient Medical Data Questionnaire (PMDQ) Date: Page 1 of 2 Medical History / Review Of Systems How do …
PRODUCT MONOGRAPH GLICLAZIDE MR - AA …
www.aapharma.caPage 3 of 52 PrGLICLAZIDE MR Gliclazide Modified Release Tablets PART I: HEALTH PROFESSIONAL INFORMATION SUMMARY PRODUCT INFORMATION Route of …
Group 1 Cardiovascular and related conditions …
www.qantas.com.auTravel Clearance Guidelines Document owner: Director of Medical Services QMS 300 V2.2 November 2015
DRUG NAME: Goserelin - BC Cancer
www.bccancer.bc.caGoserelin DRUG NAME: Goserelin SYNONYM: Decapeptide I1 COMMON TRADE NAME(S): ZOLADEX®, ZOLADEX® LA CLASSIFICATION: hormonal agent Special pediatric considerations are noted when applicable, otherwise adult provisions apply.
KLACID, KLACID IV 1. Product Name 2. Qualitative …
www.medsafe.govt.nzPage 6 of 31 Use of any antimicrobial therapy, such as clarithromycin, to treat H. pylori infection may select for drug-resistant organisms.
RCEOP in Diffuse Large B Cell Lymphoma …
www.medednhsl.comFirst line treatment of Diffuse Large B Cell Lymphoma (includes grade 3b follicular lymphoma) in patients not eligible for an anthracycline. Please note: the replacement of doxorubicin with etoposide in this patient group is established local
Medical Application Form - Orient Life
www.orientlife.aeORIENT INSURANCE PJSC P.O. Box 27966, Dubai – UAE Tel.: +971 4 253 1300 Fax: +971 4 251 5079 www.insuranceuae.com Medical Application Form …